Glaukos Corporation logo

Glaukos Corporation (GKOS)

Market Closed
3 Jun, 20:00
NYSE NYSE
$
113. 64
+2.86
+2.58%
$
6.06B Market Cap
- P/E Ratio
- Div Yield
1,095,171 Volume
-2.19 Eps
$ 110.78
Previous Close
Add Transaction
Day Range
108.76 115.47
Year Range
73.16 148.11
Want to track GKOS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Glaukos Corporation (GKOS) Q2 2025 Earnings Call Transcript

Glaukos Corporation (GKOS) Q2 2025 Earnings Call Transcript

Glaukos Corporation (NYSE:GKOS ) Q2 2025 Earnings Conference Call July 30, 2025 4:30 PM ET Company Participants Alex R. Thurman - Senior VP & CFO Christopher William Lewis - Vice President of Investor Relations & Corporate Affairs Joseph E.

Seekingalpha | 10 months ago
Glaukos (GKOS) Reports Q2 Loss, Tops Revenue Estimates

Glaukos (GKOS) Reports Q2 Loss, Tops Revenue Estimates

Glaukos (GKOS) came out with a quarterly loss of $0.24 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to a loss of $0.52 per share a year ago.

Zacks | 10 months ago
Glaukos Ramps Up iDose TR, Battles Legacy and Reimbursement Risks

Glaukos Ramps Up iDose TR, Battles Legacy and Reimbursement Risks

GKOS posts record Q1 on iDose TR strength, but reimbursement hurdles and legacy declines may hurt its near-term outlook.

Zacks | 10 months ago
What Makes Glaukos (GKOS) a New Buy Stock

What Makes Glaukos (GKOS) a New Buy Stock

Glaukos (GKOS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks | 11 months ago
Can Glaukos (GKOS) Climb 34.4% to Reach the Level Wall Street Analysts Expect?

Can Glaukos (GKOS) Climb 34.4% to Reach the Level Wall Street Analysts Expect?

The mean of analysts' price targets for Glaukos (GKOS) points to a 34.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Zacks | 11 months ago
Here's Why You Should Retain Glaukos Stock in Your Portfolio

Here's Why You Should Retain Glaukos Stock in Your Portfolio

GKOS continues to benefit from robust product demand and expansion in new markets. A strong development pipeline raises optimism.

Zacks | 1 year ago
Glaukos (GKOS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Glaukos (GKOS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Glaukos (GKOS) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks | 1 year ago
GKOS Stock Falls Despite Q1 Earnings & Revenue Beat, Margins Decline

GKOS Stock Falls Despite Q1 Earnings & Revenue Beat, Margins Decline

Glaukos' first-quarter results showcase a strong uptick in revenues. However, continued operating loss remains a cause of concern.

Zacks | 1 year ago
Glaukos Corporation (GKOS) Q1 2025 Earnings Call Transcript

Glaukos Corporation (GKOS) Q1 2025 Earnings Call Transcript

Glaukos Corporation (NYSE:GKOS ) Q1 2025 Earnings Conference Call April 30, 2025 4:30 PM ET Company Participants Chris Lewis - Vice President of Investor Relations and Corporate Affairs Tom Burns - Chairman and CEO Joe Gilliam - President and COO Alex Thurman - CFO Conference Call Participants Tom Stephan - Stifel Ryan Zimmerman - BTIG Larry Biegelsen - Wells Fargo Allen Gong - J.P. Morgan David Saxon - Needham Adam Maeder - Piper Sandler Joanne Wuensch - Citibank Margaret Andrew - William Blair Richard Newitter - Truist Securities Michael Sarcone - Jefferies Anthony Petrone - Mizzou Group Danielle Antalffy - UBS Patrick Wood - Morgan Stanley Operator Welcome to Glaukos Corporation First Quarter 2025 Financial Results Conference Call.

Seekingalpha | 1 year ago
Glaukos (GKOS) Reports Q1 Loss, Tops Revenue Estimates

Glaukos (GKOS) Reports Q1 Loss, Tops Revenue Estimates

Glaukos (GKOS) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.33. This compares to loss of $0.70 per share a year ago.

Zacks | 1 year ago
Glaukos (GKOS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Glaukos (GKOS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Glaukos (GKOS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 1 year ago
Here's Why You Should Retain Glaukos Stock in Your Portfolio

Here's Why You Should Retain Glaukos Stock in Your Portfolio

GKOS continues to benefit from robust product demand and expansion in new markets. A strong development pipeline raises optimism.

Zacks | 1 year ago
Loading...
Load More